This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Illinois. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations by Cari Launiere in Tumor Cell Capture Technology.
Introduction
Cari Launiere is an accomplished inventor based in Chicago, IL (US). She has made significant contributions to the field of medical technology, particularly in the area of cancer research. Her innovative work focuses on methods for capturing circulating tumor cells, which are crucial for early cancer detection and treatment.
Latest Patents
Cari Launiere holds a patent for a groundbreaking method and devices for capturing circulating tumor cells (CTCs). This patent describes a method that involves introducing a sample into a microfluidic device equipped with a cell capture surface and a flow modification surface. The process allows a CTC to bind to a cell rolling-inducing agent and a capturing agent on the cell capture surface. The flow modification surface induces a rotational flow within the sample as it moves through the device, enhancing the efficiency of cell capture.
Career Highlights
Cari Launiere is affiliated with the University of Illinois, where she continues to advance her research in cancer diagnostics. Her work has garnered attention for its potential to improve patient outcomes through more effective cancer detection methods. With 1 patent to her name, she exemplifies the innovative spirit of researchers dedicated to making a difference in healthcare.
Collaborations
Cari collaborates with esteemed colleagues, including Seungpyo Hong and David T Eddington. Their combined expertise contributes to the development of cutting-edge technologies in the medical field.
Conclusion
Cari Launiere's contributions to the field of tumor cell capture technology highlight her role as a leading inventor in medical research. Her innovative methods have the potential to transform cancer diagnostics and improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
